IP Library Patent Application 17223768
Patent Application
App. No. 17/223,768

METHODS FOR ISOLATION OF PLATELETS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/223,768
Abstract

Provided herein are methods for the isolation of platelets, for example, isolation of platelets from umbilical cord blood. In certain embodiments, presented herein are methods for preparation of platelet rich plasma. In one aspect, provided herein are methods for isolation of platelets from blood. In certain embodiments, presented herein are methods for isolation of platelets from cord blood, e.g., human cord blood. The isolated platelets can be used for a variety of applications, including, for example, methods of wound healing, organ repair and/or regeneration, and/or tissue repair and/or regeneration, in either autologous or allogeneic settings.

Claims (34)

1 . A method for isolation of platelets from umbilical cord blood or blood obtained from placenta, the method comprising: removing erythrocytes from the umbilical cord blood or blood obtained from placenta to produce plasma, and separating leukocytes from the plasma.

2 . The method of claim 1 , wherein the erythrocytes are removed by centrifugation of the blood.

3 . The method of claim 2 , wherein the erythrocytes are removed by introducing a plasma volume expander into the blood.

4 . The method of claim 3 , wherein erythrocytes are spontaneously sedimented following introduction of the plasma volume expander into the blood.

5 . The method of claim 3 , wherein erythrocytes are sedimented by centrifugation following introduction of the plasma volume expander into the blood.

6 . The method of claim 3 , wherein the plasma volume expander is hetastarch or pentastarch.

7 . The method of claim 1 , wherein the plasma is centrifuged for a time sufficient to separate leukocytes from platelets in the plasma, thereby producing platelet rich plasma (PRP).

8 . (canceled)

9 . (canceled)

10 . (canceled)

11 . (canceled)

12 . (canceled)

13 . (canceled)

14 . A method for isolation of platelets from umbilical cord blood or blood obtained from a placenta, the method comprising: centrifuging the blood at about 100×G to about 500×G for about 10 minutes to about 30 minutes, thereby producing PRP.

15 . The method of claim 14 , comprising centrifuging the blood at about 100×G to about 200×G.

16 . The method of claim 14 , comprising centrifuging the blood for about 20 to about 25 minutes.

17 . The method of claim 7 , further comprising buffering the PRP.

18 . The method of claim 7 , further comprising cryopreserving the PRP.

19 . The method of claim 18 , wherein cryopreserving the PRP comprises freezing the PRP.

20 . The method of claim 18 , wherein cryopreserving the PRP comprises freeze drying the PRP.

21 . The method of 20 , further comprising storing the freeze dried PRP at room temperature under vacuum.

22 . (canceled)

23 . (canceled)

24 . (canceled)

25 . (canceled)

26 . (canceled)

27 . The method of claim 26 , wherein cryopreserving the platelets comprises freezing the platelets.

28 . The method of claim 26 , wherein cryopreserving the platelets comprises freeze drying the platelets.

29 . The method of 28 , further comprising storing the freeze dried platelets at room temperature under vacuum.

30 . (canceled)

31 . The method of claim 1 , wherein the cord blood is human cord blood.

32 . (canceled)

33 . The method of claim 1 , wherein the blood is from human placenta.

34 - 37 . (canceled)

Assignments (2)
MERGER Recorded Feb 24, 2023
From: ANTHROGENESIS CORPORATION
To: CLARITY ACQUISITION II LLC
Reel/Frame 062795/0601 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2023
From: CLARITY ACQUSITION II LLC
To: CELULARITY INC.
Reel/Frame 062852/0750 →